Insmed Incorporated
INSM NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 6, 2026
ET
EPS Est.
-0.67
EPS Actual
-0.06
Revenue Est.
$395.5M
Revenue Actual
$425.5M
Next Earnings Report
Date
Oct 29, 2026 · Thu
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
-0.37
Revenue Est.
$501.2M
Company Overview
Insmed Incorporated (ticker INSM) is listed on NASDAQ with a market cap of about $27.26B. Its next earnings report (FY2026 Q3) is expected on Oct 29, 2026 (ET), Pre-market, with consensus EPS of -0.37. In the last 15 reported quarters, EPS beat consensus estimates 3 times.
Actual EPS TrendRecently15Term · Feb 23, 2023 → Aug 6, 2026
Feb 23, 2023Range: -1.94 ~ -0.06Aug 6, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 6, 2026 | -- | -0.67 | Above forecast↑-0.06 | $395.5M | $425.5M |
| May 7, 2026 | -- | -0.96 | Above forecast↑-0.76 | $300.8M | $306M |
| Feb 19, 2026 | -- | -1.07 | Below forecast↓-1.54 | $231.2M | $263.8M |
| Oct 30, 2025 | -- | -1.33 | Below forecast↓-1.75 | $115.4M | $142.3M |
| Aug 7, 2025 | -- | -1.30 | Below forecast↓-1.70 | $104.1M | $107.4M |
| May 8, 2025 | -- | -1.34 | -1.42 | $91.5M | $92.8M |
| Feb 20, 2025 | -- | -1.17 | -1.32 | $102.1M | $104.4M |
| Oct 31, 2024 | -- | -1.20 | -1.27 | $93.4M | $93.4M |
| Aug 8, 2024 | -- | -1.24 | Below forecast↓-1.94 | $88M | $90.3M |
| May 9, 2024 | -- | -1.24 | -1.06 | $77.8M | $75.5M |
| Feb 22, 2024 | -- | -1.13 | -1.28 | $82.4M | $83.7M |
| Oct 26, 2023 | -- | -1.06 | -1.10 | $79.1M | $79.1M |
| Aug 3, 2023 | -- | -1.10 | Below forecast↓-1.78 | $70.2M | $77.2M |
| May 4, 2023 | -- | -1.08 | -1.17 | $64.5M | $65.2M |
| Feb 23, 2023 | -- | -1.00 | Below forecast↓-1.20 | $62.1M | $59.3M |
Original Filings (SEC)
8-K2026-08-06 ↗
10-Q2026-08-06 ↗
8-K2026-07-16 ↗
8-K2026-05-15 ↗
8-K2026-05-07 ↗
10-Q2026-05-07 ↗
8-K2026-04-07 ↗
8-K2026-03-23 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
